KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Change in Receivables (2016 - 2025)

Rigel Pharmaceuticals has reported Change in Receivables over the past 11 years, most recently at $5.8 million for Q4 2025.

  • For Q4 2025, Change in Receivables fell 47.12% year-over-year to $5.8 million; the TTM value through Dec 2025 reached $10.1 million, down 8.29%, while the annual FY2025 figure was $10.1 million, 8.29% down from the prior year.
  • Change in Receivables for Q4 2025 was $5.8 million at Rigel Pharmaceuticals, down from $6.0 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $126.2 million in Q1 2021 and troughed at -$124.8 million in Q2 2021.
  • A 5-year average of $1.8 million and a median of $936500.0 in 2021 define the central range for Change in Receivables.
  • On a YoY basis, Change in Receivables climbed as much as 28087.14% in 2021 and fell as far as 6138.85% in 2021.
  • Year by year, Change in Receivables stood at $481000.0 in 2021, then surged by 5054.89% to $24.8 million in 2022, then plummeted by 71.75% to $7.0 million in 2023, then surged by 57.62% to $11.0 million in 2024, then plummeted by 47.12% to $5.8 million in 2025.
  • Business Quant data shows Change in Receivables for RIGL at $5.8 million in Q4 2025, $6.0 million in Q3 2025, and -$1.6 million in Q2 2025.